Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Axonics Gains After Boston Scientific Says It Will End Use Of Coaptite On Nov 1 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Axonics gains after Boston Scientific says it will end use of Coaptite on Nov. 1 - MSN
Axonics (NASDAQ:AXNX) quickly rose 1% after Boston Scientific (BSX) said it will no longer offer Coaptite as of Nov. 1. Investors believe the announcement may mean that Boston Scientific (BSX ... Read More
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
After the Nov. 15 announcement, shares of BSX jumped 3.3%, finishing at $90.45 in yesterday’s session. Boston Scientific is consistently gaining market share within its MedSurg segment. Read More
Boston Scientific to Acquire Axonics For About $3.7 Billion - WSJ - The Wall Street Journal
The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion. Read More
Axonics gains after Boston Scientific says it will end use of Coaptite on Nov. 1 - Seeking Alpha
Axonics (NASDAQ:AXNX) quickly rose 1% after Boston Scientific (BSX) said it will no longer offer Coaptite as of Nov. 1. Investors believe the announcement may mean that Boston Scientific (BSX ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus